Marianne D. De Backer
Johnson and Johnson Pharmaceutical Research and Development
Department GI Emerging Diseases
Turnhoutseweg 30
B-2340
Belgium
Name/email consistency: high
- Progress in functional genomics approaches to antifungal drug target discovery. De Backer, M.D., Van Dijck, P. Trends Microbiol. (2003)
- RNA-mediated gene silencing in non-pathogenic and pathogenic fungi. De Backer, M.D., Raponi, M., Arndt, G.M. Curr. Opin. Microbiol. (2002)
- Single allele knock-out of Candida albicans CGT1 leads to unexpected resistance to hygromycin B and elevated temperature. De Backer, M.D., de Hoogt, R.A., Froyen, G., Odds, F.C., Simons, F., Contreras, R., Luyten, W.H. Microbiology (Reading, Engl.) (2000)
- Recent developments in molecular genetics of Candida albicans. De Backer, M.D., Magee, P.T., Pla, J. Annu. Rev. Microbiol. (2000)
- Transformation of Candida albicans by electroporation. De Backer, M.D., Maes, D., Vandoninck, S., Logghe, M., Contreras, R., Luyten, W.H. Yeast (1999)
- Structure of the human histamine H1 receptor gene. De Backer, M.D., Loonen, I., Verhasselt, P., Neefs, J.M., Luyten, W.H. Biochem. J. (1998)
The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.








